BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 6:41:00 PM | Browse: 925 | Download: 758
Publication Name World Journal of Cardiology
Manuscript ID 1970
Country Greece
Received
2013-01-17 12:30
Peer-Review Started
2013-01-17 19:04
To Make the First Decision
2013-02-01 21:41
Return for Revision
2013-02-03 18:43
Revised
2013-03-05 04:28
Second Decision
2013-05-18 16:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-05-19 23:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-06-06 15:28
Publish the Manuscript Online
2013-06-28 16:48
ISSN 1949-8462 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Review
Article Title Mechanisms of drug-induced proarrhythmia in clinical practice
Manuscript Source Invited Manuscript
All Author List Arkadia Konstantopoulou, Spyros Tsikrikas, Dimitrios Asvestas, Panagiotis Korantzopoulos and Konstantinos P Letsas
Funding Agency and Grant Number
Corresponding Author Konstantinos P Letsas, MD, FESC, Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, 45-47, Ipsilantou st., 10676 Athens, Greece. k.letsas@mail.gr
Key Words Drugs; Sudden cardiac death; Long QT syndrome; Short QT syndrome; Brugada syndrome
Core Tip A growing number of cardiac and non-cardiac agents have been shown to alter cardiac repolarization predisposing to the most dangerous cardiac arrhythmias such as ventricular tachycardia or ventricular fibrillation and sudden cardiac death. These agents may induce the phenotype of long QT syndrome and less commonly of short QT syndrome and Brugada syndrome. Treating physicians are advised to follow the lists of agents implicated in drug-induced proarrhythmia in order to minimize the risk of arrhythmia and sudden cardiac death.
Publish Date 2013-06-28 16:48
Citation Konstantopoulou A, Tsikrikas S, Asvestas D, Korantzopoulos P, Letsas KP. Mechanisms of drug-induced proarrhythmia in clinical practice. World J Cardiol 2013; 5(6): 175-185
URL http://www.wjgnet.com/1949-8462/full/v5/i6/175.htm
DOI http://dx.doi.org/10.4330/wjc.v5.i6.175
Full Article (PDF) WJC-5-175.pdf
Manuscript File 1970-Review.doc
Answering Reviewers 1970-Answering reviewers.doc
Copyright License Agreement 1970-Copyright assignment.doc
Peer-review Report 1970-Peer review(s).pdf
Scientific Editor Work List 1970-Scientific editor work list.doc